Hello and Welcome to Patientsville.com, Your Source for all INTEGRILIN information. We are dedicated to provide You with INTEGRILIN safety information. Learn about INTEGRILIN serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
INTEGRILIN Safety Reports
Total INTEGRILIN reports: 100.INTEGRILIN FDA safety alerts: No.
Reported deaths: 28 Reported hospitalizations: 40.
Take INTEGRILIN Side Effects Survey or Share Your INTEGRILIN Story. Read More Here.
Showing 1-75 of 100 Next >
Physician from UNITED STATES reported INTEGRILIN problem on Aug 04, 2006. Male patient was diagnosed with acute myocardial infarction and was treated with INTEGRILIN. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase mb increased, carotid artery disease, creatinine renal clearance decreased, haemorrhage intracranial, heart rate decreased, troponin increased. INTEGRILIN dosage: unknown. During the same period patient was treated with ASPIRIN, PLAVIX. Patient died.INTEGRILIN problem was reported by a Physician from UNITED STATES on Aug 29, 2006. Female patient, 77 years of age, weighting 138.5 lb, was treated with INTEGRILIN. After drug was administered, patient experienced the following problems/side effects: cardiogenic shock, chronic obstructive pulmonary disease, coagulopathy, coronary artery disease, injection site haemorrhage, international normalised ratio increased, retroperitoneal haemorrhage. INTEGRILIN dosage: 10 ML; QH; IV. During the same period patient was treated with HEPARIN, PLAVIX, COUMADIN, ASPIRIN, LOPRESSOR, VYTORIN. Patient died on 03/31/2006.
Physician from UNITED STATES reported INTEGRILIN problem on Sept 14, 2006. Female patient, 77 years of age, weighting 138.5 lb, was treated with INTEGRILIN. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, cardiogenic shock, chronic obstructive pulmonary disease, coagulopathy, coronary artery disease, haemoglobin decreased, haemorrhage, hypotension, international normalised ratio increased. INTEGRILIN dosage: 10 ML;QH;IV. During the same period patient was treated with HEPARIN, PLAVIX, ASPIRIN, LOPRESSOR, VYTORIN. Patient died on 03/31/2006.
INTEGRILIN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 21, 2006. Female patient, 72 years of age, weighting 140.0 lb, was diagnosed with coronary arterial stent insertion, myocardial infarction and was treated with INTEGRILIN. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, aortic arteriosclerosis, aortic valve incompetence, arteriosclerosis coronary artery, atelectasis, brain herniation, bronchiolitis, cardiomegaly, cerebral arteriosclerosis. INTEGRILIN dosage: unknown. During the same period patient was treated with LOVENOX, TENECTEPLASE, ASPIRIN, PLAVIX, NORMAL SALINE, VERSED, FENTANYL. Patient was hospitalized. Patient died on 08/24/2004.
Health Professional from UNITED STATES reported INTEGRILIN problem on Oct 05, 2006. Female patient was treated with INTEGRILIN. After drug was administered, patient experienced the following problems/side effects: cardiac tamponade, iatrogenic injury, vascular rupture. INTEGRILIN dosage: unknown. Patient recovered.
INTEGRILIN problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 24, 2006. Male patient, 72 years of age, was diagnosed with cardiac arrest and was treated with INTEGRILIN. After drug was administered, patient experienced the following problems/side effects: tracheal haemorrhage. INTEGRILIN dosage: unknown. During the same period patient was treated with HEPARIN. Patient was hospitalized. Patient died on 10/21/2006.
Physician from UNITED STATES reported INTEGRILIN problem on Oct 27, 2006. Female patient, 52 years of age, weighting 210.0 lb, was diagnosed with coronary artery bypass and was treated with INTEGRILIN. After drug was administered, patient experienced the following problems/side effects: coronary artery restenosis. INTEGRILIN dosage: unknown. During the same period patient was treated with BIVALIRUDIN, CLOPIDOGREL, ASPIRIN. Patient was hospitalized. Patient recovered.
INTEGRILIN problem was reported by a Health Professional from UNITED STATES on Oct 24, 2006. Male patient, 80 years of age, was diagnosed with percutaneous coronary intervention and was treated with INTEGRILIN. After drug was administered, patient experienced the following problems/side effects: gastrointestinal haemorrhage, post procedural haemorrhage. INTEGRILIN dosage: unknown. Patient died on 10/01/2006.
Physician from FRANCE reported INTEGRILIN problem on Oct 31, 2006. Female patient, 82 years of age, was diagnosed with acute coronary syndrome and was treated with INTEGRILIN. After drug was administered, patient experienced the following problems/side effects: coronary artery thrombosis, toxic skin eruption. INTEGRILIN dosage: unknown. During the same period patient was treated with INIPOMP, CLOPIDOGREL, GLICLAZIDE, PERINDOPRIL ERBUMINE, VASTEN, ISOPTIN, PULMICORT. Patient was hospitalized. Patient recovered.
INTEGRILIN problem was reported by a Pharmacist from UNITED STATES on Nov 20, 2006. Male patient, 78 years of age, was diagnosed with acute myocardial infarction and was treated with INTEGRILIN. After drug was administered, patient experienced the following problems/side effects: haemoptysis. INTEGRILIN dosage: 75 MG ONCE IV. During the same period patient was treated with ASPIRIN, METOPROLOL SUCCINATE, LISINOPRIL, REGULAR INSULIN, TAMSULOSIN. Patient recovered.
Pharmacist from UNITED STATES reported INTEGRILIN problem on Nov 21, 2006. Male patient, 85 years of age, was diagnosed with acute myocardial infarction and was treated with INTEGRILIN. After drug was administered, patient experienced the following problems/side effects: thrombocytopenia, upper gastrointestinal haemorrhage. INTEGRILIN dosage: unknown. During the same period patient was treated with LOVENOX, ZOSYN, AMIODARONE, ASPIRIN, PEPCID, LOPRESSOR, LEVOPHED, PROPOFOL. Patient was hospitalized. Patient recovered.
INTEGRILIN problem was reported by a Pharmacist from UNITED STATES on Nov 30, 2006. Male patient, 70 years of age, was diagnosed with acute myocardial infarction and was treated with INTEGRILIN. After drug was administered, patient experienced the following problems/side effects: thrombocytopenia. INTEGRILIN dosage: unknown. During the same period patient was treated with HEPARIN, ACCUPRIL, AMBIEN, ASPIRIN, LIPITOR, NORVASC, PLAVIX, TOPROL. Patient recovered.
Pharmacist from UNITED STATES reported INTEGRILIN problem on Nov 30, 2006. Male patient, 81 years of age, was diagnosed with myocardial infarction and was treated with INTEGRILIN. After drug was administered, patient experienced the following problems/side effects: arteriogram coronary, gastrointestinal haemorrhage. INTEGRILIN dosage: unknown. During the same period patient was treated with HEPARIN, ASPIRIN, LIPITOR, ACEON, VICODIN. Patient was hospitalized. Patient recovered.
INTEGRILIN problem was reported by a Pharmacist from UNITED STATES on June 28, 2007. Female patient, 62 years of age, was treated with INTEGRILIN. After drug was administered, patient experienced the following problems/side effects: procedural complication, thrombosis. INTEGRILIN dosage: unknown. During the same period patient was treated with LOVENOX, PLAVIX. Patient recovered.
Pharmacist from UNITED STATES reported INTEGRILIN problem on June 28, 2007. Female patient, 52 years of age, was treated with INTEGRILIN. After drug was administered, patient experienced the following problems/side effects: procedural complication, thrombosis. INTEGRILIN dosage: unknown. During the same period patient was treated with LOVENOX, HEPARIN. Patient recovered.
INTEGRILIN problem was reported by a Pharmacist from UNITED STATES on July 13, 2007. Female patient, 68 years of age, was diagnosed with coronary angioplasty, myocardial infarction and was treated with INTEGRILIN. After drug was administered, patient experienced the following problems/side effects: heparin-induced thrombocytopenia, retroperitoneal haemorrhage. INTEGRILIN dosage: unknown. During the same period patient was treated with LOVENOX. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported INTEGRILIN problem on July 16, 2007. Female patient, 77 years of age, was treated with INTEGRILIN. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, post procedural complication, pulmonary alveolar haemorrhage. INTEGRILIN dosage: unknown. During the same period patient was treated with VANCOMYCIN, LORAZEPAM, PLAVIX, POTASSIUM CHLORIDE, FUROSEMIDE, ALBUTEROL, HEPARIN. Patient died on 02/14/2006.
INTEGRILIN problem was reported by a Consumer or non-health professional from CANADA on July 17, 2007. Male patient, 47 years of age, was treated with INTEGRILIN. After drug was administered, patient experienced the following problems/side effects: cerebral ischaemia, cerebrovascular accident, injection site haemorrhage, mouth haemorrhage, myocardial infarction, thrombocytopenia, thrombosis. INTEGRILIN dosage: unknown. During the same period patient was treated with PLAVIX, ASPIRIN, HEPARIN. Patient recovered.
Consumer or non-health professional from CANADA reported INTEGRILIN problem on July 26, 2007. Male patient, 52 years of age, was treated with INTEGRILIN. After drug was administered, patient experienced the following problems/side effects: cardiogenic shock, thrombocytopenia, ventricular tachycardia. INTEGRILIN dosage: unknown. During the same period patient was treated with ASPIRIN, CLOPIDOGREL, INSULIN, PROPOFOL, DIGOXIN, CARVEDILOL, ROCURONIUM BROMIDE, NITROGLYCERIN. Patient was hospitalized. Patient recovered.
INTEGRILIN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 10, 2007. Female patient, 61 years of age, was diagnosed with myocardial infarction and was treated with INTEGRILIN. After drug was administered, patient experienced the following problems/side effects: haemoptysis. INTEGRILIN dosage: 9 MG/HR 18 HRS IV. During the same period patient was treated with HEPARIN, ASPIRIN, PLAVIX, ZANTAC, QUINAPRIL, COREG, ATORVASTATIN CALCIUM. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported INTEGRILIN problem on Aug 09, 2007. Female patient, 75 years of age, was diagnosed with myocardial infarction and was treated with INTEGRILIN. After drug was administered, patient experienced the following problems/side effects: creatinine renal clearance decreased, overdose, peritoneal haemorrhage, post procedural haemorrhage, procedural complication. INTEGRILIN dosage: unknown. Patient died on 01/01/2007.
INTEGRILIN problem was reported by a Physician from UNITED STATES on Aug 16, 2007. Female patient, 61 years of age, weighting 181.0 lb, was diagnosed with percutaneous coronary intervention and was treated with INTEGRILIN. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, ventricular fibrillation, vomiting. INTEGRILIN dosage: 6 MG; ONCE; INBO, 13 ML; QH; INDRP. During the same period patient was treated with ANGIOMAX, ATROPINE, EPINEPHRINE, HEPARIN, ASPIRIN. Patient was hospitalized. Patient recovered.
Physician from FRANCE reported INTEGRILIN problem on Aug 31, 2007. Female patient, 60 years of age, was diagnosed with myocardial infarction and was treated with INTEGRILIN. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, acute respiratory distress syndrome, pulmonary alveolar haemorrhage, pulmonary haemorrhage. INTEGRILIN dosage: unknown. During the same period patient was treated with KARDEGIC, HEPARIN, ATENOLOL, PLAVIX. Patient was hospitalized and became disabled. Patient recovered.
INTEGRILIN problem was reported by a Health Professional from UNITED STATES on Sept 05, 2007. Male patient, 70 years of age, weighting 238.1 lb, was diagnosed with catheterisation cardiac, percutaneous coronary intervention and was treated with INTEGRILIN. After drug was administered, patient experienced the following problems/side effects: arterial injury, cardiac procedure complication, coagulation time prolonged, condition aggravated. INTEGRILIN dosage: unknown. During the same period patient was treated with BIVALIRUDIN, HEPARIN. Patient recovered.
Physician from FRANCE reported INTEGRILIN problem on Sept 17, 2007. Male patient, 75 years of age, was diagnosed with acute coronary syndrome and was treated with INTEGRILIN. After drug was administered, patient experienced the following problems/side effects: dermatitis bullous, haemoptysis, petechiae, pyrexia, thrombocytopenia. INTEGRILIN dosage: 7 MG; ONCE; INBO; 12 ML; QH; INDRP. During the same period patient was treated with HEPARIN, LOVENOX, PLAVIX, ACETYLSALICYLATE LYSINE, NITRIDERM, SOTALEX, AMLOR, FINASTERIDE. Patient was hospitalized. Patient recovered.
Showing 1-75 of 100 Next >